Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis

This study is ongoing, but not recruiting participants.

Study NCT00082173 Information provided by FDA Office of Orphan Products Development

First Received: April 30, 2004 Last Updated: December 26, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2008
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)

No publications provided by FDA Office of Orphan Products Development

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Conde MB, Efron A, Loredo C, De Souza GR, Graça NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet. 2009 Apr 4;373(9670):1183-9.